What should you know about aria flow cytometry?

The report should be interpreted from its specimen type, marker panel and conclusion rather than from the word ARIA alone.

Flow cytometry passes suspended cells through a laser and records their physical features and labelled proteins. Groups of cells with an unusual combination of markers may support a blood or lymphatic cancer diagnosis, classification or follow-up assessment.

A report may describe a population as abnormal, clonal or not detected. Those phrases need context: the tested sample may not contain the affected cells, and some diagnoses require cell appearance, tissue architecture, chromosome testing or molecular results as well.

Confirm whether the sample came from blood, bone marrow, fluid or tissue, because results from one site do not automatically describe every site. Request the interpretive conclusion and ask how it fits with the blood count and microscopic examination.

If the sample had too few viable cells or the report is inconclusive, the clinician may consider a repeat sample or a complementary test. Do not change treatment based only on a list of marker names.

Flow cytometry is performed in the laboratory, so any immediate physical concern usually relates to how the sample was collected. Contact the care team promptly for worsening redness, warmth, swelling, drainage, fever or bleeding at a marrow or tissue sampling site.

Seek urgent care for uncontrolled bleeding, fainting, chest pain, severe breathing difficulty or a rapidly worsening reaction after collection.

Useful questions include what ARIA means in this laboratory, whether an abnormal cell population was found, whether the specimen was adequate, which tests must be combined with this result and when the integrated diagnosis will be available.